VEGFA and neoplasm: The resulting vehicles, with high VEGF siRNA protection and low cytotoxicity, were readily internalized into cells, escaped from the endolysosomes, and released the VEGF siRNA into the cytoplasm, leading to excellent RNAi efficiency in tumor cells for enhanced VEGF knockdown in vitro and in vivo.